XSHG
600774
Market cap345mUSD
Oct 09, Last price
7.92CNY
1D
0.89%
1Q
21.10%
Jan 2017
-54.35%
Name
Wuhan Hanshang Group Co Ltd
Chart & performance
P/E
—
P/S
2.26
EPS
—
Div yield, %
—
Shrs. gr., 5y
5.48%
Rev. gr., 5y
15.81%
Revenues
1.03b
-12.23%
Net income
-175m
L+1,098.54%
CFO
113m
-41.13%
Dividend
Jul 17, 20230.06 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hanshang Group Co., Ltd. primarily engages in the retail business. It is also involved in medicine, medical equipment, assisted reproduction, healthy drinks, and exhibition operations. The company was incorporated in 1990 and is based in Wuhan, China.
Key people
Qing Zhang
Vice Chairman of the Board, General Manager · since 2016
Lin Zhang
Finance Director · since 2010
Shouchang Huang
Deputy General Manager · since 1990
Fang Yang
Deputy General Manager · since 2009
Xianhua Yao
Deputy General Manager · since 1999
Shaolan Yu
Deputy General Manager · since 2009
Jing Shang
Secretary of the Board · since 2019
Vice Chairman of the Board · since 2020
Sanjiu Feng
Director · since 2013
Director · since 2013
Benyan Li
Independent Director · since 2010
Mingxian Wei
Independent Director · since 2013
Tianrong Yuan
Independent Director · since 2010
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||